Biomanufacturing Technology Summit

Printer-friendly versionPrinter-friendly versionPDF versionPDF version



FRIDAY, JUNE 13, 2014
8:00 am

Emerging Strategies for the Production and Characterization of Biosimilars

The biomanufacturing industry faces an unprecedented challenge with the emergence of biosimilars.  The pathway to approval for biosimilars is a fluid process and several key aspects are still not determined.  The University of Maryland and the National Institute of Standards and Technology (NIST) will deliver a one-day symposium on the current trends of characterization and production of biosimilars.  On Friday, June 13, 2014 at 8:30 am join the thought-leaders, policy-makers, and creators of biosimilars as we present current trends, ideas, and predictions.

MORNING SESSION:
Bioanalytical Characterization of Biosimilars

AFTERNOON SESSION:
Biosimilar Characterization: Perspectives from the Biopharma Industry

EVENT CO-HOSTS:
Dr. Thomas Fuerst, Director, Institute for Bioscience Biotechnology Research (IBBR)
Dr. Willie May, NIST Associate Director for Laboratory Programs
Dr. Darryll Pines, Dean, University of Maryland Clark School of Engineering

REGISTRATION:
The Biomanufacturing Technology Summit registration fee for attendees is $99. Registration includes access to speaker presentations, panel sessions and content, plus breakfast, lunch, breaks, and the evening networking reception. Seating is limited so register today.


AGENDA

REGISTRATION

SPONSORSHIP OPPORTUNITIES

VENUE/HOTEL/TRAVEL

CONTACTS

DOWNLOADS